The aim of this study is to examine whether PD patients carrying pathogenic variants in LRRK2 gene (mutLRRK2‐PD) have a higher prevalence of malignancies compared to PD non mutated in LRRK2 gene (wtLRRK2‐PD). The gene discussed is LRRK2; the disease is Parkinson disease.